Yao L - Search Results

1

Dec1 expression predicts prognosis and the response to temozolomide chemotherapy in patients with glioma.

Li XM, Lin W, Wang J, Zhang W, Yin AA, Huang Y, Zhang J, Yao L, Bian H, Zhang J, Zhang X. Li XM, et al. Among authors: yao l. Mol Med Rep. 2016 Dec;14(6):5626-5636. doi: 10.3892/mmr.2016.5921. Epub 2016 Nov 3. Mol Med Rep. 2016. PMID: 27840944

2

RNAi-mediated inhibition of MSP58 decreases tumour growth, migration and invasion in a human glioma cell line.

Lin W, Zhang J, Zhang J, Liu X, Fei Z, Li X, Davidovic L, Tang Z, Shen L, Deng Y, Yang A, Han H, Zhang X, Yao L. Lin W, et al. Among authors: yao l. J Cell Mol Med. 2009 Nov-Dec;13(11-12):4608-22. doi: 10.1111/j.1582-4934.2008.00499.x. J Cell Mol Med. 2009. PMID: 18798870 Free PMC article.

3

Increased expression of discoidin domain receptor 2 (DDR2): a novel independent prognostic marker of worse outcome in breast cancer patients.

Ren T, Zhang J, Zhang J, Liu X, Yao L. Ren T, et al. Among authors: yao l. Med Oncol. 2013 Mar;30(1):397. doi: 10.1007/s12032-012-0397-3. Epub 2013 Jan 10. Med Oncol. 2013. PMID: 23307244

4

Tumor suppressor candidate gene, NDRG2 is frequently inactivated in human glioblastoma multiforme.

Zhou B, Tang Z, Deng Y, Hou S, Liu N, Lin W, Liu X, Yao L. Zhou B, et al. Among authors: yao l. Mol Med Rep. 2014 Aug;10(2):891-6. doi: 10.3892/mmr.2014.2237. Epub 2014 May 14. Mol Med Rep. 2014. PMID: 24840052

5

Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines.

Liu N, Wang L, Liu X, Yang Q, Zhang J, Zhang W, Wu Y, Shen L, Zhang Y, Yang A, Han H, Zhang J, Yao L. Liu N, et al. Among authors: yao l. Biochem Biophys Res Commun. 2007 Jun 22;358(1):164-9. doi: 10.1016/j.bbrc.2007.04.089. Epub 2007 Apr 20. Biochem Biophys Res Commun. 2007. PMID: 17470364

6

NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.

Yu C, Wu G, Li R, Gao L, Yang F, Zhao Y, Zhang J, Zhang R, Zhang J, Yao L, Yuan J, Li X. Yu C, et al. Among authors: yao l. Cancer Biol Ther. 2015;16(2):287-96. doi: 10.1080/15384047.2014.1002348. Cancer Biol Ther. 2015. PMID: 25756511 Free PMC article.

7

KLF4 inhibits colorectal cancer cell proliferation dependent on NDRG2 signaling.

Ma Y, Wu L, Liu X, Xu Y, Shi W, Liang Y, Yao L, Zheng J, Zhang J. Ma Y, et al. Among authors: yao l. Oncol Rep. 2017 Aug;38(2):975-984. doi: 10.3892/or.2017.5736. Epub 2017 Jun 21. Oncol Rep. 2017. PMID: 28656310

8

Immunohistochemical detection of Ndrg2 in the mouse nervous system.

Shen L, Zhao ZY, Wang YZ, Ji SP, Liu XP, Liu XW, Che HL, Lin W, Li X, Zhang J, Yao LB. Shen L, et al. Among authors: yao lb. Neuroreport. 2008 Jun 11;19(9):927-31. doi: 10.1097/WNR.0b013e32830163d0. Neuroreport. 2008. PMID: 18520995

9

Overexpression of N-Myc downstream-regulated gene 2 (NDRG2) regulates the proliferation and invasion of bladder cancer cells in vitro and in vivo.

Li R, Yu C, Jiang F, Gao L, Li J, Wang Y, Beckwith N, Yao L, Zhang J, Wu G. Li R, et al. Among authors: yao l. PLoS One. 2013 Oct 16;8(10):e76689. doi: 10.1371/journal.pone.0076689. eCollection 2013. PLoS One. 2013. PMID: 24146910 Free PMC article.

10

Functional and clinical evidence that TAZ is a candidate oncogene in hepatocellular carcinoma.

Guo Y, Pan Q, Zhang J, Xu X, Liu X, Wang Q, Yi R, Xie X, Yao L, Liu W, Shen L. Guo Y, et al. Among authors: yao l. J Cell Biochem. 2015 Nov;116(11):2465-75. doi: 10.1002/jcb.25117. J Cell Biochem. 2015. PMID: 25650113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,907 results

Search Page

Filters